CME price to sales ratio CME
Market value divided by revenue over the last twelve months, since 2010.
- Today, Oct 23, 2026
- 16.2×
- 10-year median
- 14.4×
- Against its 10-year history
- 85th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 9.7× to 19.1×
- Peer median
- 7.0×
CME's price to sales ratio is 16.2× as of Oct 23, 2026.
That is above its ten-year median of 14.4×, higher than on 85% of days in the last ten years.
Over that time it ranged from 9.7× in Oct 2016 to 19.1× in Mar 2022.
The median for 8 financial data and exchange stocks of a similar size is 7.0×.
Price to sales ratio over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 16.2× | 11.8× | 17.6× |
| 2025 | 15.6× | 13.7× | 16.6× |
| 2024 | 13.9× | 12.4× | 14.7× |
| 2023 | 14.2× | 12.4× | 15.1× |
| 2022 | 12.2× | 12.2× | 19.1× |
| 2021 | 17.7× | 13.3× | 17.7× |
| 2020 | 13.3× | 10.6× | 15.9× |
| 2019 | 14.6× | 13.6× | 17.4× |
| 2018 | 16.0× | 13.9× | 16.8× |
| 2017 | 13.6× | 10.9× | 14.2× |
| 2016 | 11.2× | 8.5× | 11.9× |
| 2015 | 9.1× | 9.1× | 10.8× |
| 2014 | 10.3× | 7.7× | 10.5× |
| 2013 | 9.1× | 6.0× | 9.7× |
| 2012 | 5.6× | 4.7× | 6.2× |
| 2011 | 4.9× | 4.8× | 7.3× |
| 2010 | 7.4× | 5.7× | 7.9× |
Against its peers
Companies in Financial - Data & Stock Exchanges nearest CME's size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| CMECME | 16.2× |
| ICEIntercontinental Exchange | 6.8× |
| SPGIS&P Global | 8.2× |
| MCOMoody's | 10.3× |
| NDAQNasdaq | 6.6× |
| MSCIMSCI | 13.4× |
| COINCoinbase Global | 6.9× |
| CBOECboe Global Markets | 7.0× |
| TRUTransUnion | 3.2× |
| Peer median | 7.0× |
Where CME ranks
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on CME
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.